Dr Josselin Nespoux (Ph.D.)
Postdoctoral Research Fellow

Contact details
- Email: j.nespoux@ed.ac.uk
Address
- Street
-
Centre for Cardiovascular Science
Queen's Medical Research Institute
Edinburgh BioQuarter
47 Little France Crescent - City
- Edinburgh
- Post code
- EH16 4TJ
Background
Josselin Nespoux is an early-career renal physiologist with training from Université de Poitiers, University of Utah, University of California San Diego, and University of Edinburgh. Dr. Nespoux is currently a Postdoctoral Research Fellow at the Centre for Cardiovascular Science, Edinburgh, where he conducts research aiming at better understanding the interplay between renal, vascular and immune systems in health and disease. Dr. Nespoux works under the supervision of Pr. Neeraj Dhaun and Pr. Matt Bailey.
Research summary
Renal physiology, hypertension and chronic kidney disease (CKD)
Current research interests
The interplay between immune, renal and vascular systems in the pathogenesis of hypertension and cardiovascular disease --- Retinal imaging in mice as a tool for understanding microvascular health in kidney disease --- The role of leucine-rich alpha-2 glycoprotein 1 (LRG1) in the pathogenesis of acute and chronic kidney diseasesPast research interests
The purinergic P2X7 receptor in renal haemodynamics physiology, and kidney inflammation and injury --- Glucose transport in acute kidney injury (AKI)Kim YC, Fattah H, Fu Y, Nespoux J, Vallon V.
Am J Physiol Renal Physiol. 2023 Jun 1;324(6):F544-F557. doi:10.1152/ajprenal.00279.2022. Epub 2023 Apr 27. PMID: 37102688
Western Diet Promotes Renal Injury, Inflammation, and Fibrosis in a Murine Model of Alström Syndrome.
Kim YC, Ganguly S, Nespoux J, Freeman B, Zhang H, Brenner D, Dhar D, Vallon V.
Nephron. 2020;144(8):400-412. doi:10.1159/000508636. Epub 2020 Jul 6. PMID: 32629454
Nespoux J, Patel R, Zhang H, Huang W, Freeman B, Sanders PW, Kim YC, Vallon V.
Am J Physiol Renal Physiol. 2020 May 1;318(5):F1100-F1112. doi:10.1152/ajprenal.00607.2019. Epub 2020 Mar 2. PMID: 32116018
Renal effects of SGLT2 inhibitors: an update.
Nespoux J, Vallon V.
Curr Opin Nephrol Hypertens. 2020 Mar;29(2):190-198. doi:10.1097/MNH.0000000000000584. PMID: 31815757 Review.
Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.
Onishi A, Fu Y, Darshi M, Crespo-Masip M, Huang W, Song P, Patel R, Kim YC, Nespoux J, Freeman B, Soleimani M, Thomson S, Sharma K, Vallon V.
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F419-F434. doi:10.1152/ajprenal.00497.2018. Epub 2019 Jun 5. PMID: 31166707
Nespoux J, Patel R, Hudkins KL, Huang W, Freeman B, Kim YC, Koepsell H, Alpers CE, Vallon V.
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1201-F1210. doi:10.1152/ajprenal.00111.2019. Epub 2019 Apr 17. PMID: 30995111
SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
Novikov A, Fu Y, Huang W, Freeman B, Patel R, van Ginkel C, Koepsell H, Busslinger M, Onishi A, Nespoux J, Vallon V.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F173-F185. doi:10.1152/ajprenal.00462.2018. Epub 2018 Nov 14. PMID: 30427222
SGLT2 inhibition and kidney protection.
Nespoux J, Vallon V.
Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi:10.1042/CS20171298. Print 2018 Jun 29.PMID: 29954951 Review.